GLNKX | RSEBX | GLNKX / RSEBX | |
Total Expense Ratio | 1.60 | 1.45 | 110% |
Annual Report Gross Expense Ratio | 2.06 | 1.45 | 142% |
Fund Existence | 14 years | 11 years | - |
Gain YTD | 11.158 | 9.281 | 120% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 76.8M | 79.8B | 0% |
Annual Yield % from dividends | 0.13 | 0.23 | 57% |
Returns for 1 year | 12.00 | 9.34 | 128% |
Returns for 3 years | 31.67 | 31.03 | 102% |
Returns for 5 years | 19.52 | 16.78 | 116% |
Returns for 10 years | 56.54 | 43.37 | 130% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GMVRX | 16.50 | 0.15 | +0.92% |
Goldman Sachs Small/Mid Cap Equity R | |||
SBQUX | 13.39 | 0.12 | +0.90% |
AmericaFirst Alpha Trends Factor Class U | |||
FCDTX | 35.10 | 0.30 | +0.86% |
Fidelity Advisor Stock Selector Sm Cp M | |||
PHLAX | 33.09 | 0.17 | +0.52% |
PGIM Jennison Health Sciences A | |||
FGIWX | 12.88 | -0.01 | -0.08% |
Nuveen Global Infrastructure R6 |